GALMED PHARMACEUTICALS LTD. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GALMED PHARMACEUTICALS LTD. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $190.00K.
- GALMED PHARMACEUTICALS LTD. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $6.04M.
- GALMED PHARMACEUTICALS LTD. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $1.44M.
- GALMED PHARMACEUTICALS LTD. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $17.37M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $7.67M 20-F · filed 2026-03-31 | |
| 2025-09-30 | $190.00K 6-K · filed 2025-11-26 | |
| 2025-06-30 | $6.04M 6-K · filed 2026-09-02 | |
| 2025-03-31 | $1.44M 6-K · filed 2026-09-02 | |
| 2022-12-31 | $70.00K 20-F · filed 2025-04-02 | |
| 2021-12-31 | $9.22M 20-F · filed 2022-05-02 | |
| 2021-03-31 | $17.37M 6-K · filed 2022-08-04 | |
| 2020-12-31 | $707.00K 20-F · filed 2021-03-18 | |
| 2018-12-31 | $79.15M 20-F · filed 2019-03-13 | |
| 2018-06-30 | $70.30M 6-K · filed 2019-08-05 | |
| 2017-12-31 | $15.02M 20-F · filed 2019-03-13 | |
| 2016-12-31 | $4.48M 20-F · filed 2018-03-13 | |
| 2014-12-31 | $2.00M 20-F · filed 2016-03-22 | |
| 2013-12-31 | $120.00K 20-F · filed 2015-03-31 |